Home > Qtrly Results > MARKSANS PHARMA

MARKSANS PHARMA
Quarterly Results Analysis [Jun2025]

MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Quarterly Results

Consolidated Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Revenues ₹620 Cr ₹708 Cr ₹682 Cr ₹642 Cr ₹591 Cr ₹560 Cr ₹586 Cr ₹531 Cr
Expenses ₹520 Cr ₹583 Cr ₹543 Cr ₹506 Cr ₹462 Cr ₹450 Cr ₹453 Cr ₹417 Cr
Operating Income ₹100 Cr ₹126 Cr ₹139 Cr ₹136 Cr ₹128 Cr ₹110 Cr ₹133 Cr ₹114 Cr
Other Income ₹6 Cr ₹17 Cr ₹28 Cr ₹11 Cr ₹15 Cr ₹17 Cr ₹5 Cr ₹19 Cr
Interest ₹6 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹3 Cr ₹5 Cr ₹3 Cr ₹2 Cr
Depreciation ₹23 Cr ₹23 Cr ₹21 Cr ₹20 Cr ₹20 Cr ₹21 Cr ₹22 Cr ₹18 Cr
Profit Before Tax ₹77 Cr ₹116 Cr ₹143 Cr ₹125 Cr ₹120 Cr ₹100 Cr ₹113 Cr ₹114 Cr
Profit After Tax ₹58 Cr ₹91 Cr ₹105 Cr ₹98 Cr ₹89 Cr ₹78 Cr ₹83 Cr ₹84 Cr
EPS ₹1.29 ₹2.00 ₹2.31 ₹2.13 ₹1.96 ₹1.73 ₹1.84 ₹1.84
Industry Peers & Returns1W1M1Y
MARKSANS PHARMA -1.3% -26.6% -16.4%
SUN PHARMACEUTICAL INDUSTRIES -0.3% -3.4% -6.9%
DIVIS LABORATORIES -1.6% -10.2% 30.3%
CIPLA -1% 4.8% -1.7%
TORRENT PHARMACEUTICALS 1.2% 3.9% 9%
DR REDDYS LABORATORIES -0.6% -1.1% -9.9%
MANKIND PHARMA 1.6% -5.3% 7.5%
ZYDUS LIFESCIENCES -0.6% 1.4% -16.5%
LUPIN -2.5% 1% -4.9%

MARKSANS PHARMA Quarterly Revenues

Revenues
Q-o-Q

-12.49 %

Y-o-Y

4.97 %

Quarters Revenues % Change
Jun2025 ₹620 Cr
-12.49
Mar2025 ₹708 Cr
3.90
Dec2024 ₹682 Cr
6.22
Sep2024 ₹642 Cr
8.69
Jun2024 ₹591 Cr
5.47
Mar2024 ₹560 Cr
-4.46
Dec2023 ₹586 Cr
10.33
Sep2023 ₹531 Cr -

MARKSANS PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-20.38 %

Y-o-Y

-22.04 %

Quarters Operating Profit % Change
Jun2025 ₹100 Cr
-20.38
Mar2025 ₹126 Cr
-9.38
Dec2024 ₹139 Cr
2.27
Sep2024 ₹136 Cr
5.64
Jun2024 ₹128 Cr
17.14
Mar2024 ₹110 Cr
-17.58
Dec2023 ₹133 Cr
16.74
Sep2023 ₹114 Cr -
Operating Margins
Q-o-Q

-9.01 %

Y-o-Y

-25.75 %

Quarters Operating Margin% % Change
Jun2025 16.15%
-9.01
Mar2025 17.75%
-12.78
Dec2024 20.35%
-3.74
Sep2024 21.14%
-2.80
Jun2024 21.75%
11.08
Mar2024 19.58%
-13.74
Dec2023 22.7%
5.83
Sep2023 21.45% -

MARKSANS PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-35.85 %

Y-o-Y

-34.65 %

Quarters Profit After Tax % Change
Jun2025 ₹58 Cr
-35.85
Mar2025 ₹91 Cr
-13.65
Dec2024 ₹105 Cr
7.47
Sep2024 ₹98 Cr
9.76
Jun2024 ₹89 Cr
14.71
Mar2024 ₹78 Cr
-6.41
Dec2023 ₹83 Cr
-1.06
Sep2023 ₹84 Cr -
PAT Margins
Q-o-Q

-26.70 %

Y-o-Y

-37.73 %

Quarters PAT Margin(%) % Change
Jun2025 9.39 %
-26.70
Mar2025 12.81 %
-16.87
Dec2024 15.41 %
1.18
Sep2024 15.23 %
0.99
Jun2024 15.08 %
8.80
Mar2024 13.86 %
-2.05
Dec2023 14.15 %
-10.33
Sep2023 15.78 % -

MARKSANS PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-35.50 %

Y-o-Y

-34.18 %

Quarters EPS % Change
Jun2025 ₹1.29
-35.50
Mar2025 ₹2
-13.42
Dec2024 ₹2.31
8.45
Sep2024 ₹2.13
8.67
Jun2024 ₹1.96
13.29
Mar2024 ₹1.73
-5.98
Dec2023 ₹1.84
0.00
Sep2023 ₹1.84 -

You may also like the below Video Courses